Here's how to approach the diagnostics company for both the aggressive and timid.
Let's check the charts and indicators.
Here's why the current weakness in Bionano Genomics could be a buying opportunity.
Plus, the latest monthly ISM Manufacturing survey sends a disturbing signal about prices and a quick option play thought about Veeva Systems.
The news sent shares of the genome editing company skyward after the stock had been basing for months.
The early potential candidates for the next Tax Loss Selling Recovery Portfolio are few and far between.
Here's where traders could probe the long side of JNJ.
Traders should approach PKI from the long side at current levels.
This drugmaker is making a historic upside breakout. Let's check the charts.
Let's review the charts and indicators.